US20030225365A1 - Catheter system and method for injection of a liquid embolic composition and a solidification agent - Google Patents

Catheter system and method for injection of a liquid embolic composition and a solidification agent Download PDF

Info

Publication number
US20030225365A1
US20030225365A1 US10/388,484 US38848403A US2003225365A1 US 20030225365 A1 US20030225365 A1 US 20030225365A1 US 38848403 A US38848403 A US 38848403A US 2003225365 A1 US2003225365 A1 US 2003225365A1
Authority
US
United States
Prior art keywords
catheter
lumen
tube
embolic composition
liquid embolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/388,484
Inventor
Richard Greff
Scott Evans
Michael Jones
Original Assignee
Greff Richard J.
Scott Evans
Jones Michael L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/953,149 priority Critical patent/US6146373A/en
Priority to US09/573,154 priority patent/US6558367B1/en
Application filed by Greff Richard J., Scott Evans, Jones Michael L. filed Critical Greff Richard J.
Priority to US10/388,484 priority patent/US20030225365A1/en
Publication of US20030225365A1 publication Critical patent/US20030225365A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/12186Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • A61B2017/00495Surgical glue applicators for two-component glue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0034Multi-lumen catheters with stationary elements characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0037Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026Multi-lumen catheters with stationary elements
    • A61M2025/0039Multi-lumen catheters with stationary elements characterized by lumina being arranged coaxially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0097Catheters; Hollow probes characterised by the hub

Abstract

A catheter according to the present invention includes a multiple lumen catheter for delivery of a liquid embolic composition through a first lumen and delivery of a solidification agent through a second lumen. The catheter allows adjustment of the relative longitudinal position of the two lumens to control the solidification of the embolic composition within a blood vessel. The multiple lumen catheter system is used by inserting the catheter endovascularly into an aneurysm site and injecting a liquid embolic composition through the first lumen while injecting a solidification agent through the second lumen to wash the area of the aneurysm of blood which has become saturated with solvent, while replacing it with a fresh solidification agent. The controlled solidification of the liquid embolic composition by use of the solidification agent allows the aneurysm to be filled precisely and rapidly even when the aneurysm is located such that gravity does not cause the liquid embolic composition to flow into the aneurysm.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The invention relates to a catheter system and method for combined injection of a liquid embolic composition and an embolic solidification agent, and more particularly, to a catheter system including a multiple lumen catheter for injection of a liquid embolic composition through a first lumen and an embolic solidification agent through a second lumen. The catheter system is used for delivery of the embolic composition in a controlled manner for embolizing blood vessels. [0002]
  • 2. State of the Art [0003]
  • In many clinical situations it is desirable to selectively occlude blood vessels for a variety of purposes, such as, the control or prevention of bleeding, the prevention of blood supply to tumors, and the blocking of blood flow within an aneurysm. Embolization of blood vessels has been performed by employing certain polymer compositions and/or particulate including silicone balloons, metallic coils, PA particles, gelatin,. sclerosing material, and the like, to selectively block blood flow in the blood vessels. [0004]
  • Intracranial aneurysms are present in between one and nine percent of the population and rupture at a rate of more than 50,000 per year in North America. Intracranial aneurysms are abnormal blood filled dilations of a blood vessel wall which may rupture causing significant bleeding and damage to surrounding brain tissue or death. Traditionally, intracranial aneurysms have been surgically clipped to reduce the risk of rupture by placing a metal clip around the neck of the aneurysm to cut off and prevent further blood flow to the aneurysm. However, many aneurysms cannot be treated surgically because of either the location and configuration of the aneurysm or because the condition of the patient does not permit cranial surgery. [0005]
  • When aneurysms cannot be treated surgically or when surgery is considered to be too risky or invasive, aneurysms may be treated endovascularly with coils. The coils are placed in the aneurysm by extending a catheter endovascularly to the site of the aneurysm and passing single or often multiple platinum or tungsten coils through the catheter into the aneurysm. The coils placed within the aneurysm create a thrombus which occludes the aneurysm and prevents further blood flow to the aneurysm. The treatment of intracranial aneurysms with coils isolates the aneurysm from arterial circulation helping to guard against rupture and further growth of the aneurysm. However, the use of platinum coils to treat intracranial aneurysms may not be a permanent solution because the blood clot around the coils may declot or dissolve due to the dynamic nature of the blood clotting function. Once a clot formed around the coils in an aneurysm declots, the coil can no longer perform its function of occluding the aneurysm. In addition, the coils may become dislodged and enter the patient's blood stream causing blockages at other locations within the vascular system. [0006]
  • Another drawback associated with the use of coils to occlude an aneurysm is that the coils are known to compact over time leaving cavities for subsequent aneurysm growth. In addition, if a subsequent surgical clipping procedure is warranted, it can be difficult to place the clip over the coil mass. [0007]
  • Aneurysms having large necks are not easily treated by either surgical clipping or by coils because the aneurysm neck may have a shape which cannot be completely clipped surgically and the coils may tend to become dislodged from the aneurysm when the neck is particularly large. [0008]
  • One minimally invasive procedure for treating intracranial aneurysms which addresses the problems with the surgical clipping and coil techniques involves the endovascular injection of a liquid embolic composition which solidifies in the aneurysm to occlude the aneurysm. The liquid embolic composition generally includes a water-insoluble, biocompatible polymer and a biocompatible solvent. Once the liquid embolic composition is injected into the aneurysm, the biocompatible solvent dissipates into the blood and the polymer solidifies to occlude the blood flow through the aneurysm. [0009]
  • Typically, liquid embolic compositions include a water insoluble, biocompatible, non-biodegradable polymer dissolved in a biocompatible solvent and preferably these compositions include a radiopaque material which allows the physician to view the embolization procedure by fluoroscopy. Prior to delivery of the embolic composition to the aneurysm, the aneurysm and delivery device are preferably positioned so that the liquid embolic composition will be delivered by gravity into the aneurysm and will remain in the aneurysm (with the aneurysm neck pointing up). As the embolic composition is delivered to the aneurysm, the solvent dissipates from the polymer material causing the polymer material within the aneurysm to solidify. [0010]
  • Depending on the rate at which the liquid embolic material is injected into the blood vessel and the amount of blood flow present, the polymer may remain in liquid form for a period of time while the solvent dissipates into the blood stream. Moreover, the solvent may not be completely dissipated from a center of the polymer mass creating a mass with a solid outer shell and liquid interior. In addition, the solvent concentration at the point of injection may increase to a point where small strings of unsolidified polymer material may separate from the polymer mass and be carried away in the blood stream where it can occlude an undesired vascular location. Since the solvent generally has a density greater than water or blood, gravity may hold the solvent in the aneurysm and prevent the polymer from solidifying. [0011]
  • Accordingly, it would be desirable to provide a method for controlling the solidification of the polymer material during injection. It would also be desirable to provide a method for filling an aneurysm which is riot positioned such that gravity may be used to cause the embolic composition to flow into and remain in the aneurysm, since a patient's anatomical position cannot always be in a gravity dependent position. [0012]
  • As disclosed in U.S. patent application Ser. No. 08/730,701, embolization of a blood vessel with a liquid embolic composition generally includes a preparatory step of flushing a delivery catheter through which the liquid embolic composition is to be delivered with the biocompatible solvent material to remove any aqueous material from the catheter. The removal of any aqueous material from the catheter inhibits solidification of the embolic composition within the catheter during delivery. This preliminary step of flushing with the solvent must be done at a slow flow rate to prevent damage to the blood vessel caused by high concentrations of the solvent which can be toxic and may cause vascular spasms. However, it would be desirable to be able to perform the preliminary flushing of the delivery catheter without concern of causing tissue damage. [0013]
  • SUMMARY OF THE INVENTION
  • According to one aspect of the invention a catheter system for controlled delivery of polymer compositions includes a multiple lumen catheter having a first lumen and a second lumen for delivery of fluid. A first fluid delivery port delivers fluid to the first lumen and a liquid supply is connected to the first fluid delivery port for delivery of a liquid embolic composition through the first lumen. A second fluid delivery port delivers fluid to the second lumen and a solidification agent supply is connected to the second fluid delivery port for delivery of a solidification agent through the second lumen to enhance solidification of the liquid embolic composition delivered through the first lumen. [0014]
  • According to a further aspect of the invention a catheter for controlled delivery of embolic compositions includes a first tube formed of a DMSO compatible material, a second tube connected to the first tube and an actuator for sliding the first tube longitudinally with respect to the second tube. A first fluid delivery port is connected to a lumen of the first tube for delivery of a liquid embolic composition including a biocompatible, water insoluble, polymer composition dissolved in DMSO. A second fluid delivery port is connected to a lumen of the second tube for delivery of a solidification agent which encourages dissipation of the DMSO and solidification of the polymer composition. [0015]
  • According to an additional aspect of the invention a method of embolizing a vascular site such as an aneurysm with a liquid embolic composition includes the steps of inserting a multiple lumen catheter endovascularly to a vascular site, injecting a liquid embolic composition through a first lumen of the multiple lumen catheter at the vascular site, and controlling solidification of the liquid embolic composition within the vascular site by injecting a solidification agent through a second lumen of the multiple lumen catheter at the vascular site. [0016]
  • In accordance with a further aspect of the present invention, a method for reducing toxic effects of a non-aqueous solvent delivered intravascularly includes positioning a multi-lumen catheter into a vascular site of a mammal, injecting a composition comprising a non-aqueous solvent through a first lumen of the multiple lumen catheter at the vascular site, and injection an aqueous solution through at least a second lumen of the multiple lumen catheter at the vascular site to dilute the non-aqueous solvent and reduce toxic effects of the non-aqueous solvent on surrounding tissue. [0017]
  • In accordance with another aspect of the present invention, a kit for controlled delivery in vivo of a liquid embolic composition includes a liquid embolic composition, and a multiple lumen catheter for delivery of liquid embolic composition through a first lumen and delivery of a solidification agent through a second lumen.[0018]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be described in greater detail with reference to the accompanying drawings in which like elements bear like reference numbers, and wherein: [0019]
  • FIG. 1 is a side view of the catheter system according to the present invention; [0020]
  • FIG. 2 is an exploded side view of the catheter system of FIG. 1; [0021]
  • FIG. 3 is an enlarged cross-sectional view of the multiple lumen catheter taken along line [0022] 3-3 of FIG. 1;
  • FIG. 4 is an enlarged cross-sectional view of the multiple lumen catheter taken along line [0023] 4-4 of FIG. 1;
  • FIG. 5 is an enlarged cross-sectional view of the multiple lumen catheter taken along line [0024] 5-5 of FIG. 1;
  • FIG. 6 is an enlarged side cross-sectional view of an aneurysm being treated by the method according to the present invention; [0025]
  • FIG. 7 is an enlarged side cross-sectional view of an aneurysm showing the detachment of an embolic mass from the catheter; [0026]
  • FIG. 8 is an enlarged perspective view of a distal end of a catheter according to a first alternative embodiment of the invention; [0027]
  • FIG. 9 is an enlarged perspective view of a distal end of a catheter according to a second alternative embodiment of the invention; [0028]
  • FIG. 10 is an enlarged cross-sectional view of the distal end of a catheter according to a third alternative embodiment of the invention; and [0029]
  • FIG. 11 is an enlarged cross-sectional view of a distal end of a catheter according to a fourth alternative embodiment of the invention.[0030]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The catheter system of FIG. 1 includes a catheter having at least two lumens for delivery of a liquid embolic composition through a first lumen and delivery of a solidification agent through a second lumen. The liquid embolic composition and the solidification agent are delivered to the two lumens through a catheter connector which allows adjustment of the relative longitudinal positions of the two lumens. The catheter system is used to embolize vascular sites by controlled solidification of the embolic composition within such sites. [0031]
  • The catheter system [0032] 10 includes an inner tube 12, an outer tube 14, and proximal end connector 16 also called a Y-connector or Y-fitting for connection of fluid supplies to the inner and outer tubes. The outer tube 14 is positioned coaxially around the inner tube 12 forming an annular lumen between the inner and outer tubes and an annular outlet of the outer tube. The inner tube 12 is movable within the outer tube 14 by an actuator 18 and can be locked in place with respect to the outer tube by a locking mechanism 20.
  • The method according to the present invention involves the insertion of the multiple lumen catheter of the catheter system [0033] 10 endovascularly to a vascular site such as an aneurysm and injecting a liquid embolic composition through a first lumen while injecting a solidification agent through a second lumen to control solidification of the liquid embolic composition. The controlled solidification of the liquid embolic composition allows the vascular site to be filled more precisely and rapidly, even when the aneurysm is located such that gravity does not cause the liquid embolic to remain in such sites.
  • Prior to discussing the present invention in further detail, the following terms are defined: [0034]
  • The term “embolic composition” refers to a fluid composition that is injected into a blood vessel and solidifies to fully or partially occlude the vascular site. [0035]
  • The term “embolizing” or “embolization” refers to a process wherein a fluid composition is injected into a blood vessel which, in the case of, for example, aneurysms, fills or plugs the aneurysm sac and/or encourages clot formation so that blood flow into the aneurysm and pressure in the aneurysm ceases, and in the case of arterial venous malformations (AVMs) and arterial venous fistula (AVFs) forms a plug or clot to control/reroute blood flow to permit proper tissue perfusion. Embolization may be used for preventing/controlling bleeding due to lesions (e.g., organ bleeding, gastrointestinal bleeding, vascular bleeding, as well as bleeding associated with an aneurysm). In addition, embolization can be used to ablate diseased tissue (e.g., tumors, etc.) by cutting off its blood supply. [0036]
  • The term “biocompatible polymer” refers to polymers which, in the amounts employed, are non-toxic, chemically inert, and substantially non-immunogenic when used internally in the patient and which are substantially insoluble in blood and other aqueous solutions but are soluble in the fluid composition to the degree necessary to form a solid mass in vivo. [0037]
  • The term “contrast agent” refers to both water insoluble and aqueous based contrast agents which are visible by x-ray, fluoroscopy, CT scan, MRI, or the like. [0038]
  • The term “biocompatible solvent” refers to solvents capable of dissolving the selected biocompatible polymer which are miscible or soluble in aqueous compositions (e.g., blood). Suitable biocompatible solvents include ethanol, dimethylsulfoxide (DMSO), ethyl lactate, acetone, and the like as well as aqueous mixtures thereof having no more than about 30 percent water. When employed at this level, the amount of water is sufficiently small that the dissolved polymer precipitates upon contact with the blood. Preferably, the biocompatible solvent is anhydrous and, even more preferably, the biocompatible solvent is anhydrous dimethylsulfoxide (DMSO). [0039]
  • The term “solidification agent” refers to a liquid composition which when in proximity to the liquid embolic composition, increases the rate at which the liquid embolic composition solidifies. Examples of such solidification agents include sterile water, sterile saline, Dextrose 5% water (D5W), lactated Ringers solution, contrast agents and the like. [0040]
  • The term “catheter” includes both catheters and microcatheters. The catheters and microcatheters are designed for use in the highly tortuous blood vessels of the body, such as, intracranial blood vessels. By highly tortuous, we mean the typical tortuosity encountered in the vascular pathway from a remote access site such as the femoral artery to target sites deep within in the coronary, renal, and cerebral vasculature. Specific embodiments may be constructed for access into target sites involving pathologically tortuous blood vessels, and by pathological tortuosity, we mean that the vascular pathway from a remote access site such as the femoral artery to target sites involves turns in excess of 90° when branching off from one blood vessel to another blood vessel (paths which branch off the proceeding vessel at angles greater than a right angle), and where the total path length within the target tissue is at least about 5 cm and is also characterized as being accessible by a guidewire 0.018 inches or smaller, but being too delicate and/or tortuous for accessing by a significantly larger diameter guidewire. [0041]
  • FIGS. 1 and 2 illustrate the catheter system [0042] 10 according to the present invention through which the liquid embolic composition and the solidification agent are injected into a vascular site to achieve controlled solidification of the liquid embolic composition within the blood vessel. As illustrated in the exploded view of FIG. 2, a proximal end of the inner tube 12 extends through a rigid tube 22 which stabilizes the proximal end of the inner tube. The proximal ends of the rigid tube 22 and the inner tube 12 are connected to the actuator 18. The actuator 18 is positioned on a first luer hub 24 and includes a substantially flat rectangular manipulator which is grasped by the physician to move the inner tube 12 longitudinally within the outer tube 14. The rigid tube 22 is positioned within the connector 16 with a stop 26 of the rigid tube arranged between corresponding first and second stops 28, 30 within the connector 16. The first and second stops 28, 30 of the connector 16 engage the stop 26 of the rigid tube 22 to limit the longitudinal motion of the inner tube 12 with respect to the outer tube 14.
  • According to an alternative embodiment, proximal motion of the actuator [0043] 18 and the inner tube 12 is limited by engagement of the stop 26 with the second stop 30. Distal motion of the inner tube 12 with respect to the outer tube 14 is limited by engagement of the actuator 18 with the locking mechanism 20.
  • The first luer hub [0044] 24 is positioned proximally of the actuator 18 and provides mating means for mating with a syringe (not shown) filled with the liquid embolic composition. A preferred luer hub/syringe combination is illustrated in U.S. patent application Ser. No. 08/866,208 which is incorporated herein by reference in its entirety. Although the liquid embolic composition would generally be delivered to the catheter by a syringe in a quantity which may be continuously controlled by the physician, it may also be injected by other means such as a high pressure injector or pump.
  • The catheter connector [0045] 16 includes a Y-arm 32 with a second luer hub 34 which provides mating means for mating with a supply of the solidification agent. The Y-arm 32 extends from a side of the main body of the connector 16 for delivery of the solidification agent to the interior of the connector. From the interior of the connector 16 the solidification agent passes into the annular lumen between the outer tube 14 and the inner tube 12. The outer tube 14 is connected to the connector 16 by a distal end cap 46 of the connector. The outer tube 14 may be connected by a compression fit by trapping the proximal end of the tube between the connector 16 and the end cap 46 by a threaded connection. The outer tube 14 may also be connected to the connector by adhesive bonding, insert molding, and the like. The solidification agent may be delivered to the outer tube 14 through the Y-arm 32 from a variety of sources, such as, a gravity feed saline bag, a pump, a high pressure injector, or a syringe.
  • An anti-kinking feature of the present invention is provided to prevent kinking of the inner tube [0046] 12 as it is pushed distally within the outer tube 14. The anti-kinking feature includes an outer rigid tube 48 which is press fit within the stop 28. The stop 28 is in turn press fit within the main body of the connector 16. The inner rigid tube 22 slides within the somewhat larger outer rigid tube 48 to guide the inner tube 12 within the outer tube 14 without kinking. When the inner rigid tube 22 has been moved proximally until the stop 26 of the rigid tube engages the stop 30, an end of the inner rigid tube remains inside the outer rigid tube 48. Without the rigid tubes 22, 48, it would not be possible to slide the inner tube 12 into the outer tube 14 because the flexible inner tube would fold up within the connector 16.
  • The outer rigid tube [0047] 48 extends from the stop 28 toward the distal end cap 46. However, the outer rigid tube 48 ends before a proximal end of the outer tube 14 providing a gap. Accordingly, the fluid injected through the luer hub 34 passes around the outer rigid tube 48, through the gap between outer rigid tube and the outer tube 14, and into the outer tube.
  • The locking mechanism [0048] 20 for locking the relative longitudinal positions of the inner tube 12 and the outer tube 14 is best shown in the exploded view of FIG. 2. The locking mechanism 20 includes an externally threaded end 36 of the connector 16, a rotatable cap 38 having internal threads, and a resilient sealing member 40. When the connector 16 is assembled with the inner tube 12 positioned within the outer tube 14 the sealing member 40 is positioned around the rigid tube 22 connected to the inner catheter tube 12. The sealing member 40 has a shape which includes an annular tapered surface at each end and a through bore for receiving the rigid tube 22. The opposite annular tapered surfaces of the sealing member 40 engage correspondingly tapered surfaces 42, 44 inside the connector 16 and inside a distal end of the rotatable cap 38, respectively. In a preferred embodiment of the present invention, the sealing member 40 is a type of seal called a Tuohy-Borst seal.
  • The rigid tube [0049] 22 is placed inside the connector 16 such that the inner tube 12 is slidable within the outer tube 14, and the rigid tube 22 is slidable within the connector and the rigid tube 48. As the rotatable cap 38 is tightened onto the threaded end 36 of the connector 16 the sealing member 40 is compressed between the tapered internal surface 42 of the connector 16 and the tapered internal surface 44 of the cap. As the sealing member 40 is compressed longitudinally it expands radially inwardly and radially outwardly to lock the rigid tube 22 in place within the connector 16 and to provide a fluid tight seal between the interior surfaces of the connector and the exterior surface of the rigid tube. In this manner, the locking mechanism 20 freezes the ends of the inner and outer tubes 12, 14 with respect to each other.
  • The inner and outer tubes [0050] 12, 14 for use in the present invention are particularly designed to have sufficient rigidity to be inserted with or without a guide wire to a location within a blood vessel for embolization and to have sufficient flexibility at the distal end to prevent damage to tissue. In order to achieve these objectives, of rigidity at the proximal end and flexibility at the distal end, the inner and outer tubes 12, 14 may each be formed of two segments of differing flexibilities joined together. The joints between the distal and proximal segments of the inner and outer tubes are longitudinally staggered resulting in the three different cross sections of the catheter illustrated in FIGS. 3-5. Although the invention is described as employing catheter segments joined by joints, the catheter segments of differing cross-sections and flexibilities may be extruded together as a single piece to avoid the need for joints. Alternatively, the inner and outer tubes 12, 14 may have a continuously changing flexibility along their lengths.
  • As shown in FIG. 3, a proximal segment [0051] 12 a of the inner tube 12 is formed of a material having a preferred durometer of approximately 40 Shore D to 90 Shore D, more preferably approximately 60 Shore D to 80 Shore D, and a diameter D1. A proximal segment 14 a of the outer tube 14 is formed of a material having a preferred durometer of approximately 40 Shore D to 90 Shore D, more preferably approximately 60 Shore D to 80 Shore D, and a diameter D2.
  • The proximal segment [0052] 14 a of the outer tube 14 having the diameter D2 is fused to a distal segment 14 b of the outer tube which has a smaller diameter D3, shown in FIG. 4. The distal segment 14 b of the outer tube 14 has a durometer which is smaller than that of the proximal segment 14 a. Preferably, the durometer of the distal segment 14 b is approximately 40 Shore A to 45 Shore D more preferably approximately 80 Shore A to 100 Shore A. The transition between the segments 14 a, 14 b of the outer tube 14 occurs between the section line 3-3 and the section line 4-4 in FIG. 1. This transition between the distal and proximal segments 14 a, 14 b of the outer tube 14 is located along the length of the catheter as required to allow the catheter to be tracked along a tortuous path, preferably the transition is between 15 and 20 cm from the distal end of the catheter.
  • The proximal segment [0053] 12 a of the inner tube 12 is fused to a distal segment 12 b of the inner tube, shown in FIG. 5. The proximal and distal segments 12 a, 12 b of the inner tube preferably have the same diameter D1 but are formed of different materials with different flexibilities. The distal segment 12 b of the inner tube 12 preferably has a durometer of approximately 40 Shore A to 45 Shore D, more preferably approximately 80 Shore A to 100 Shore A.
  • One example of a multiple lumen catheter employed in the present invention has a usable length of about 150 cm, a proximal portion of the outer tube which is about 3.6 French and a distal portion of the outer tube which is about 2.6 French. The wall thicknesses of the inner and outer tubes vary from about 0.003 inches (0.008 cm) to about 0.005 inches (0.013 cm), with the proximal portion of the outer tube having the largest wall thickness. The proximal portions of the inner and outer tubes are formed of high density polyethylene having a durometer of about 70 Shore D. The more flexible distal portions of the inner and outer tubes are formed of about 40% low density polyethylene and about 60% Engage by Dow. (polyolefin) having a durometer of about 35 Shore D. This catheter configuration has been described only as an-example. [0054]
  • Catheters having a size of between about 1.5 and 5.0 French may be used for treatment of aneurysms and other sizes may also be used for other types of treatments of vascular sites. The catheters may also be braided or coil reinforced and formed of a wide variety of materials. Braided or otherwise reinforced catheters provide kink resistance, crush resistance, and steerability. [0055]
  • The inner tube [0056] 12 is movable from an extended position in which the inner tube extends from the distal end of the outer tube 14 by up to about 30 mm to a retracted position in which the inner tube distal end is even with or inside the distal end of the outer tube 14. Movement of the actuator 18 in the direction of arrow A in FIG. 1 provides a corresponding movement of the distal end of the inner tube 12 in the direction of the arrow B. The inner and outer tubes 12, 14 preferably experience minimal elongation or compression such that the distance of travel of the actuator 18 is substantially the same as the distance of travel of the distal end of the inner tube 12.
  • The tip of the catheter is preferably shaped prior to use by the physician to a desired shape for the particular location and configuration of the vasculature to be treated. The tip of the catheter is shaped by placing a tip shaping mandrel in the lumen of the inner tube [0057] 12. A sleeve may also be placed in the lumen between the outer tube 14 and the inner tube 12 during shaping to support the outer tube. The catheter tip with the mandrel and the sleeve is then shaped to a desired curvature by the physician and subsequently steam heated to hold the curvature once the mandrel and sleeve have been withdrawn.
  • The method according to the present invention involves the injection of a solidification agent to control the solidification of the embolic composition within a blood vessel. The solidification agent allows for rapid, controlled solidification of the embolic composition and places more control of the embolization procedure in the hands of the physician. [0058]
  • One example of a liquid embolic composition for embolizing aneurysms includes a biocompatible, water insoluble polymer, a contrast agent, and a biocompatible solvent such as dimethylsulfoxide (DMSO). Examples of such embolizing compositions ate described in U.S. Pat. No. 5,667,767, which issued Sep. 16, 1997, U.S. Pat. No. 5,580,568, which issued on Dec. 3, 1996, and allowed U.S. patent application Ser. No. 08/688,050 each of which are incorporated herein by reference in their entirety. [0059]
  • FIG. 6 illustrates the use of the method and apparatus according to the present invention to occlude an aneurysm [0060] 70 having a relatively large neck 72 which has formed at a branch in a blood vessel 74. The aneurysm 70 is treated by inserting the, multiple lumen catheter of FIG. 1 endovascularly until a distal end of the catheter is positioned within or near the aneurysm or the neck 72 of the aneurysm. The position of the catheter tip will vary depending on the aneurysm shape, size, and flow pattern. A guide wire (not shown) positioned in the inner tube 12 may or may not be used to guide the catheter through the blood vessels. Other methods of tracking the catheter to the aneurysm include steerable systems in which the catheter tip is steered, flow directed systems, or sheath directed systems in which the catheter is delivered through a sheath. The insertion of the catheter is generally performed under fluoroscopic visualization in a known manner.
  • As shown in FIG. 6, the distal ends of the inner and outer tubes [0061] 12, 14 each have a radiopaque marker 50, 52, respectively, to allow the physician to view the relative positions of the distal ends of the two catheter tubes and the position of the catheter tubes with respect to the aneurysm 70. The radiopaque markers 50, 52 may be formed either at the inner or outer diameters of the tubes 12, 14. While tracking the catheter through a typical tortuous path, the inner tube 12 may be extended from the end of the outer tube 14 to improve the flexibility and tracking of the catheter distal end.
  • Prior to delivery of the liquid embolic composition to the aneurysm [0062] 70, the lumen 62 of the inner tube 12 is preferably flushed with a barrier fluid to remove any aqueous material, such as blood, saline, or contrast agent from the inner tube which may cause the embolic composition to solidify within the catheter and block the catheter. The catheter does not need to be entirely primed with the barrier fluid as long as the column of barrier fluid is of a sufficient length to prevent contact between the liquid embolic composition and any aqueous material in the catheter. The barrier fluid may be the biocompatible solvent or another fluid providing a barrier between aqueous fluids and the liquid embolic composition.
  • High concentrations of organic solvents such as DMSO, ethanol and others when used as barrier fluids can be toxic to tissue and may cause vascular spasms. In order to avoid the high solvent concentrations which are toxic to tissue, a dilution liquid is injected through the annular lumen [0063] 60 between the inner and outer tubes 12, 14 during injection of the barrier fluid. The dilution liquid may be the same liquid as the solidification agent, e.g., saline, or may a different liquid.
  • The injection of a dilution agent minimizes the effect of the toxicity of an organic solvent and greatly increases the solvent injection flow rate which can be used safely. Preferably, the dilution agent is injected through the lumen [0064] 60 of the outer tube 14 before or as soon as the solvent begins to exit the inner lumen 62 before any of the embolic composition has been injected. The dilution agent causes the solvent to diffuse in the vessel treatment area at a much higher rate, and therefore, the concentration of the solvent in contact with the tissue is greatly decreased. A contrast agent may be used as the dilution agent to help visualize flow characteristics of the aneurysm and determine optimum catheter placement within the aneurysm.
  • According to the method of the present invention illustrated in FIG. 6, the aneurysm [0065] 70 is treated by injection of the liquid embolic composition into the aneurysm 70 through the lumen 62 of the inner tube 12 by a syringe or other delivery mechanism attached to the luer connection 24. The solidification agent, e.g., saline, is injected through the lumen 60 of the outer tube 14 in tandem or just subsequent to the injection of the liquid embolic composition. The solidification agent may be injected in a continuous or a pulsatile manner. The solidification agent washes the area of the aneurysm of blood which has become saturated with solvent, replacing it with fresh solidification agent. The washing action of the solidification agent is used to remove blood and other viscous fluids in the aneurysm which are otherwise difficult to displace. In addition, the solidification agent provides a diffusion bed of solidification agent and increases the diffusion gradient which improves the diffusion of the solvent from the embolic composition as the composition solidifies in a coherent mass.
  • Without the use of the solidification agent the solvent concentration gradient between the liquid embolic composition being injected and the surrounding blood decreases as the solvent dissipates from the embolic composition slowing the rate at which the solvent diffuses from the embolic composition. The solidification agent is used to increase the solvent concentration gradient which causes the solvent diffusion rate to increase. [0066]
  • According to an alternative embodiment of the invention, the liquid embolic composition and solidification agent are injected alternately rather than simultaneously. The injection of liquid embolic composition alone will form a nearly spherical shape. The liquid embolic injection may then be discontinued while the solidification agent is injected to solidify the spherically shaped mass of liquid embolic. The timing of the injection of the liquid embolic composition and the solidification agent may be varied to achieve different results. [0067]
  • The inner tube [0068] 12 is slidable within the outer tube 14 so that the tip of the inner tube can be extended to different lengths from the distal end of the outer tube to further control the solidification of the embolic composition depending on the aneurysm size, shape, and flow characteristics. The injection of a fluid through the annulus between the inner and outer tubes 12, 14 may also be used to aid in the movement of the inner tube inside the outer tube by creating a moving fluid column which reduces friction between the tubes. The use of fluid as a friction reducing mechanism may be particularly useful when the catheter has been tracked through a typically tortuous path such as that provided by the blood vessels of the brain.
  • When embolization of the aneurysm is completed or is halted for some other reason, the outer tube [0069] 14 serves as a lip to disconnect the embolic mass from the catheter by retracting the inner tube 12 into the outer tube. The separation of a coherent solid mass of embolic composition E from the end of the catheter is illustrated in FIG. 7. Without the detachment mechanism provided by the movable inner tube 12, it may be difficult for the physician to separate the embolic mass E from the catheter without causing trauma to the surrounding tissue. The detachment may be provided by any one or more of the following steps: 1) retracting the inner tube 12 into the outer tube 14; 2) advancing the outer tube over the inner tube; or 3) injecting solidification agent to detach the embolic mass from the outer tube.
  • In order to visualize the flow in the area being treated, including the flow into and out of the aneurysm, the dilution agent and/or the solidification agent can be combined with a contrast agent and injected alone prior to injection of the liquid embolic composition. Further, washout can be visualized by injection of contrast agent through the inner lumen while solidification agent is injected through the annular -lumen between the inner and outer tubes [0070] 12, 14.
  • Although the present invention has been described as employing a coaxial catheter having coaxial lumens, the present invention may also employ other types of multiple lumen catheters such as those shown in FIGS. [0071] 8-11. Additional multiple lumen catheter configurations other than those shown may also be used, including catheters having multiple lumens for delivery of the liquid embolic composition and catheters having multiple lumens for delivery of the solidification agent. Further, two independent catheters may be used for separate delivery of the liquid embolic composition and the solidification agent to achieve the controlled solidification of the embolic composition according to the method of the present invention.
  • A multiple lumen catheter [0072] 80 illustrated in FIG. 8 has a first lumen 82 and a second lumen 84 positioned side by side. In this side by side embodiment, the liquid embolic composition is injected through the first lumen 82 while the solidification agent is injected through the second lumen 84.
  • As shown in FIG. 9, the outlets of the two lumens [0073] 82 a, 84 a may be longitudinally staggered so that the solidification agent injected through the second lumen 84 a washes around the outlet of the first lumen 82 a delivering the embolic composition. In addition, the side-by-side embodiments of FIGS. 8 and 9 may include means for adjusting the longitudinal position of one of the lumens with respect to the other lumen.
  • FIG. 10 illustrates another alternative embodiment of a multiple lumen catheter [0074] 90 having an inner tube 92 and an outer tube 94 coaxially surrounding the inner tube. The outer tube 94 includes a distal tapered portion,96 and a plurality of openings 98 or side holes. The liquid embolic composition is delivered through the inner tube 92 while the solidification agent is delivered through the outer tube 94 and exits both and through end of the outer tube and through the openings 98. The tapered portion 96 of the outer tube 94 causes the solidification agent to be injected at an increased velocity along the inner tube 92 and washes the liquid embolic as it is injected from the inner tube. The size and number of the openings 98 and the degree of taper may be varied to provide different amounts of flow through the end of the outer tube 94 and through the openings.
  • FIG. 11 illustrates a further alternative embodiment of a multiple lumen catheter [0075] 100 in which an outer coaxial tube 104 is fused to an inner coaxial tube 102 at a distal end of the catheter. One or more openings 106 or side holes are provided in a side wall of the outer tube, 104 for delivery of the solidification agent. The openings 106 may be particularly designed to deliver the solidification agent in a desired delivery pattern by variation of the number, size, and location of the openings.
  • Although the present invention has been described in detail for use in treatment of aneurysms, it can also be used in a variety of other applications where controlled solidification of a liquid embolic composition is desired. For example, the present invention may be used to occlude a blood vessel in order to block the blood flow to a tumor to ablate tumorous tissue. The present invention may be used to control bleeding in blood vessels by occluding a blood vessel. Further, the present invention may be used to control the solidification of a biocompatible polymer which is used for reversible sterilization or for bulking of tissues to treat urinary incontinence. [0076]
  • The injection of the solidification agent to control the solidification of the embolic composition according to the present invention is particularly useful in situations where high flow rates may carry the liquid embolic away from the embolization site before it is solidified in a mass, for example an AVF, and for situations where the position of the formation to be filled with the embolic composition does not allow the liquid embolic composition to remain by gravity in the formation. The invention may also be particularly useful in situations where the fluid flow is very low and the solvent is not carried away as it dissipates from the embolic composition. [0077]
  • The catheter for use in the present invention particularly the inner tube [0078] 12, and also the connector 16 and the actuator 18, are formed of solvent compatible materials. According to a preferred embodiment of the invention in which the solvent is DMSO, the catheter elements which may come into contact with the solvent are DMSO compatible. Examples of DMSO compatible materials and some of the preferred durometers of these materials for use in a catheter include polyolefins, such as, polyethylene (80A-80D), polyester polyether block copolymer (30D-80D), Alcryn (chlorinated polyolefin) (60A-80A), Pebax (polyamide polyether block copolymer) (25D-70D); fluoropolymers, such as, PTFE (such as Teflon), ETFE, and SEBS (styrene ethylene butadiene styrene); silicones; interpenetrating networks of silicone; and nylons (6/6, 6/10, and 6/12); and polyimide.
  • The inner and outer tubes [0079] 12, 14 are preferably coated with lubricous coatings both on their inner and outer diameters. In particular, a lubricous coating on the outer diameter of the outer tube 14 assists the insertion of the catheter, while lubricous coatings on the inner diameter of the outer tube and on the outer diameter of the inner tube 12 improve the longitudinal motion of the inner tube within the outer tube. A lubricous coating on the inner diameter of the inner tube 12 will improve guidewire movement within the catheter. The lubricous coating on the inner diameter of the inner tube 12 should be compatible with the biocompatible solvent.
  • The inner and outer rigid tubes [0080] 22, 48 within the connector 16 of the present invention may also include a keyed slot extending substantially along their lengths to prevent the relative rotation of the inner and outer tubes 12, 14 at their proximal end. For example, the inner rigid tube 22 may include an external longitudinal groove which receives an internal longitudinal rib of the outer rigid tube 48.
  • Suitable biocompatible polymers for-use in the liquid embolic composition of the present invention include, by way of example, non-biodegradable polymers such as cellulose acetates (including cellulose diacetate), ethylene vinyl alcohol copolymers, hydrogels (e.g., acrylics), polyacrylonitrile, polyvinylacetate, cellulose acetate butyrate, nitrocellulose, copolymers of urethane/carbonate, copolymers of styrene/maleic acid, and mixtures thereof. Other suitable biocompatible polymers include, for example, biodegradable polymers such as linear-chain polymers such as polylactides, polyglycolides, polycaprolactones, polyanhydrides, polyamides, polyurethanes, polyesteramides, polyorthoesters, polydioxanones, polyacetals, polyketals, polycarbonates, polyorthocarbonates, polyhydroxybutyrates, polyhydroxyvalerates, polyalkylene oxalates, polyalkylene succinates, poly(malic acid), poly(amino acids), polyhydroxycellulose, chitin, chitosan, and copolymers, terpolymers and combinations thereof. [0081]
  • Preferably, the biocompatible polymer does not cause adverse inflammatory reactions when employed in vivo. [0082]
  • The particular biocompatible polymer employed is selected relative to the viscosity of the resulting polymer solution, the solubility of the biocompatible polymer in the biocompatible solvent, and the like. Such factors are well within the skill of the art. [0083]
  • Preferred biocompatible polymers include cellulose diacetate and ethylene vinyl alcohol copolymer. Cellulose diacetate polymers are either commercially available or can be prepared by art recognized procedures. In a preferred embodiment, the number average molecular weight, as determined by gel permeation chromatography, of the cellulose diacetate composition is from about 25,000 to about 100,000 more preferably from about 50,000 to about 75,000 and still more preferably from about 58,000 to 64,000. The weight average molecular weight of the cellulose diacetate composition, as determined by gel permeation chromatography, is preferably from about 50,000 to 200,000 and more preferably from about 100,000 to about 180,000. As is apparent to one skilled in the art, with all other factors being equal, cellulose diacetate polymers having a lower molecular weight will impart a lower viscosity to the composition as compared to higher molecular weight polymers. Accordingly, adjustment of the viscosity of the composition can be readily achieved by mere adjustment of the molecular weight of the polymer composition. [0084]
  • Ethylene vinyl alcohol copolymers comprise residues of both ethylene and vinyl alcohol monomers. Small amounts (e.g., less than 5 mole percent) of additional monomers can be included in the polymer structure or grafted thereon provided such additional monomers do not alter the embolizing properties of the composition. Such additional monomers include, by way of example only, maleic anhydride, styrene, propylene, acrylic acid, vinyl acetate and the like. [0085]
  • Ethylene vinyl alcohol copolymers are either commercially available or can be prepared by art recognized procedures. Preferably, the ethylene vinyl alcohol copolymer composition is selected such that a solution of 6 weight percent of the ethylene vinyl alcohol copolymer, 25 weight percent of a tantalum contrast agent in DMSO has a viscosity equal to or less than 60 centipoise at 20° C. As is apparent to one skilled in the art, with all other factors being equal, copolymers having a lower molecular weight will impart a lower viscosity to the composition as compared to higher molecular weight copolymers. Accordingly, adjustment of the viscosity of the composition as necessary for catheter delivery can be readily achieved by mere adjustment of the molecular weight of the copolymer composition. [0086]
  • As is also apparent, the ratio of ethylene to vinyl alcohol in the copolymer affects the overall hydrophobicity/hydrophilicity of the composition which, in turn, affects the relative water solubility/insolubility of the composition as well as the rate of precipitation of the copolymer in an aqueous solution (e.g., blood). In a particularly preferred embodiment, the copolymers employed herein comprise a mole percent of ethylene of from about 25 to about 60 and a mole percent of vinyl alcohol of from about 40 to about 75. These compositions provide for requisite precipitation rates suitable for use in embolizing blood vessels. [0087]
  • While the invention has been described in detail with reference to a preferred embodiment thereof, it will be apparent to one skilled in the art that various changes and modifications can be made, and equivalents employed, without departing from the spirit and scope of the invention. [0088]

Claims (35)

What is claimed is:
1. A catheter system for controlling solidification in vivo of liquid embolic compositions which catheter system comprises:
(a) a multiple lumen catheter having a first lumen and a second lumen for delivery of fluid;
(b) a first fluid delivery port for delivery of fluid to the first lumen;
(c) a second fluid delivery port for delivery of fluid to the second lumen;
(d) a liquid supply connected to the first fluid delivery port for delivery of a liquid embolic composition through the first lumen; and
(e) a solidification agent supply connected to the second fluid delivery port for delivery of a solidification agent through the second lumen to enhance solidification of the liquid embolic composition when delivered in vivo through the first lumen.
2. The catheter system according to claim 1, wherein the multiple lumen catheter includes an inner tube and an outer tube coaxially surrounding the inner tube.
3. The catheter system according to claim 2, wherein the inner tube is longitudinally movable within the outer tube to adjust a relative position of an outlet of the inner tube with respect to an outlet of the outer tube.
4. The catheter system according to claim 3, further comprising a locking mechanism for locking a position of the inner tube with respect to the outer tube.
5. The catheter system according to claim 3, wherein the relative positions of the inner tube and the outer tube are movable from a first position in which the inner tube extends from the outlet of the outer tube, to a second position in which the outlet of the inner tube is positioned within the lumen of the outer tube, wherein the relative motion of the inner and outer tubes from the first position to the second position detaches a solidified mass of the embolic composition from the multiple lumen catheter.
6. The catheter system according to claim 1, wherein an outlet of the first lumen and an outlet of the second lumen of the multiple lumen catheter are longitudinally movable with respect to one another to change relative longitudinal positions of the outlets of the first and second lumens to control solidification of the liquid embolic composition.
7. The catheter system according to claim 1, wherein the liquid embolic composition comprises a water-insoluble, biocompatible polymer dissolved in a biocompatible solvent and the catheter is compatible with the biocompatible solvent.
8. The catheter system according to claim 7, wherein the biocompatible solvent is DMSO.
9. The catheter system according to claim 8, wherein the multiple lumen catheter is DMSO compatible.
10. The catheter system according to claim 1, wherein the biocompatible polymer is water insoluble and the solidification agent is selected from the group consisting of water, saline, Dextrose 5% water, lactated Ringers solution, and aqueous based contrast agents.
11. A catheter for controlling solidification in vivo of liquid embolic compositions comprising:
(a) a first tube formed of a DMSO compatible material;
(b) a second tube connected to the first tube;
(c) an actuator for sliding the first tube longitudinally with respect to the second tube;
(d) a first fluid delivery port connected to a lumen of the first tube for delivery of a liquid embolic composition which composition comprises a biocompatible, water-insoluble polymer dissolved in DMSO, the first delivery port formed of a DMSO compatible material; and
(e) a second fluid delivery port connected to a lumen of the second tube for delivery of a solidification agent which encourages solidification of the liquid embolic composition.
12. The catheter according to claim 11, further comprising a locking mechanism for locking a longitudinal position of the first tube with respect to the second tube.
13. The catheter according to claim 11, wherein the second tube coaxially surrounds the first tube.
14. The catheter according to claim 13, further comprising an anti-kinking mechanism for preventing kinking of the first tube as it slides in the second tube, the anti-kinking mechanism including a rigid tube connected to the first tube and slidable within a sleeve.
15. The catheter according to claim 13, wherein a distal end of the second tube includes a plurality of side holes for delivery of the solidification agent.
16. The catheter according to claim 11, wherein the first and second tubes each have a proximal portion with a durometer of between about 40 Shore D and 90 Shore D.
17. The catheter according to claim 16, wherein the first and second tubes each have a distal portion with a durometer of between about 40 Shore A and 45 Shore D.
18. The catheter according to claim 17, wherein a joint between the distal and proximal portions of the first tube is longitudinally displaced from a joint between the distal and proximal portions of the second tube at all relative positions of the catheter which are achieved by manipulation of the actuator.
19. A method of treating aneurysms with a liquid embolic composition comprising:
inserting a multiple lumen catheter endovascularly to an aneurysm site;
injecting a liquid embolic composition through a first lumen of the multiple lumen catheter at the aneurysm site; and
controlling the solidification of the liquid embolic composition within the aneurysm by injecting a solidification agent through a second lumen of the multiple lumen catheter at the aneurysm site.
20. The method of treating aneurysms according to claim 19, wherein the multiple lumen catheter is a coaxial catheter and the solidification agent is injected through an annulus between an inner and outer tube of the coaxial catheter.
21. The method of treating aneurysms according to claim 19, wherein an outlet the first lumen and an outlet of the second lumen of the multiple lumen catheter are longitudinally movable with respect to one another.22.
22. The method of treating aneurysms according to claim 21, wherein the liquid embolic composition and the solidification agent are injected when the outlets of the first and second lumens are longitudinally spaced with respect to each other.
23. The method of treating aneurysms according to claim 22, wherein the outlets of the first and second lumens of the multiple lumen catheter are manipulated with respect to one another to detach a solidified mass of embolic composition from the multiple lumen catheter.
24. The method of treating aneurysms according to claim 21, wherein a fluid is injected through one of the first and second lumens to improve longitudinal motion of the outlets of the first and second lumens with respect to one another.
25. The method of treating aneurysms according to claim 19, wherein the injected liquid embolic composition includes a biocompatible polymer composition dissolved in a solvent.
26. The method of treating aneurysms according to claim 25, wherein the first lumen is flushed-with a barrier fluid prior to injection of the liquid embolic composition to prevent aqueous fluids in the first lumen from coming into contact with the liquid embolic composition passing through the first lumen.
27. The method of treating aneurysms according to claim 26, wherein the barrier fluid includes the solvent.
28. The method of treating aneurysms according to claim 27, wherein the solidification agent is injected through the second lumen during the flushing of the first lumen with the barrier fluid to lower a concentration of the solvent being delivered to the patient.
29. The method of treating aneurysms according to claim 19, wherein the liquid embolic composition and the solidification agent are injected at the same time.
30. The method of treating aneurysms according to claim 19, wherein the liquid embolic composition and the solidification agent are injected alternately.
31. A method for reducing toxic effects of a non-aqueous solvent delivered intravascularly which method comprises:
positioning a multiple lumen catheter into a vascular site of a mammal;
injecting a composition comprising a non-aqueous solvent through a first lumen of the multiple lumen catheter at the vascular site; and
injecting an aqueous solution through at least a second lumen of the multiple lumen catheter at the vascular site to dilute the non-aqueous solvent and reduce toxic effects of the non-aqueous,-solvent on surrounding tissue.
32. The method for reducing toxic effects of a non-aqueous solvent according to claim 31, wherein the non-aqueous solvent is DMSO.
33. A kit for controlled delivery in vivo of a liquid embolic composition comprising;
a liquid embolic composition; and
a multiple lumen catheter for delivery of the liquid embolic composition through a first lumen and delivery of a solidification agent through a second lumen.
34. The kit according to claim 33, wherein the multiple lumen catheter includes an inner tube longitudinally movable within a coaxial outer tube.
35. The kit according to claim 34, wherein the multiple lumen catheter further comprises a connector introducing the liquid embolic composition and the solidification agent to the first and second lumens, the connector including an anti-kinking mechanism allowing the inner tube to move within the outer tube without kinking.
US10/388,484 1997-10-17 2003-03-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent Abandoned US20030225365A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US08/953,149 US6146373A (en) 1997-10-17 1997-10-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US09/573,154 US6558367B1 (en) 1997-10-17 2000-05-19 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US10/388,484 US20030225365A1 (en) 1997-10-17 2003-03-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/388,484 US20030225365A1 (en) 1997-10-17 2003-03-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/573,154 Continuation US6558367B1 (en) 1997-10-17 2000-05-19 Catheter system and method for injection of a liquid embolic composition and a solidification agent

Publications (1)

Publication Number Publication Date
US20030225365A1 true US20030225365A1 (en) 2003-12-04

Family

ID=25493639

Family Applications (4)

Application Number Title Priority Date Filing Date
US08/953,149 Expired - Lifetime US6146373A (en) 1997-10-17 1997-10-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US09/573,154 Expired - Lifetime US6558367B1 (en) 1997-10-17 2000-05-19 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US10/361,851 Expired - Fee Related US6964657B2 (en) 1997-10-17 2003-02-11 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US10/388,484 Abandoned US20030225365A1 (en) 1997-10-17 2003-03-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US08/953,149 Expired - Lifetime US6146373A (en) 1997-10-17 1997-10-17 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US09/573,154 Expired - Lifetime US6558367B1 (en) 1997-10-17 2000-05-19 Catheter system and method for injection of a liquid embolic composition and a solidification agent
US10/361,851 Expired - Fee Related US6964657B2 (en) 1997-10-17 2003-02-11 Catheter system and method for injection of a liquid embolic composition and a solidification agent

Country Status (9)

Country Link
US (4) US6146373A (en)
EP (1) EP1030703B1 (en)
JP (1) JP2001520085A (en)
AT (1) AT254937T (en)
AU (1) AU1697799A (en)
CA (1) CA2306992A1 (en)
DE (1) DE69820105T2 (en)
ES (1) ES2210851T3 (en)
WO (1) WO1999020326A1 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036281A1 (en) * 2004-05-21 2006-02-16 Micro Therapeutics, Inc. Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
WO2007047109A2 (en) * 2005-10-12 2007-04-26 Boston Scientific Scimed, Inc. Embolic coil introducer sheath locking mechanisms
US20080121175A1 (en) * 2003-06-26 2008-05-29 Stephen Dirk Pacetti Stent Coating Nozzle Assembly
US20100076479A1 (en) * 2004-01-21 2010-03-25 Hermann Monstadt Device for implanting electrically isolated occlusion helixes
EP2036485A3 (en) * 2006-08-28 2010-04-14 Olympus Medical Systems Corporation Ultrasonic endoscope, therapeutic system, endoscopic system, T-bar, und T-bar suturing device
US20100125324A1 (en) * 2008-11-14 2010-05-20 Medtronic Vascular, Inc. Catheter Inner Member
US7799014B2 (en) 2001-01-09 2010-09-21 Rex Medical, L.P. Dialysis catheter
US7879064B2 (en) 2004-09-22 2011-02-01 Micro Therapeutics, Inc. Medical implant
US8048104B2 (en) 2000-10-30 2011-11-01 Dendron Gmbh Device for the implantation of occlusion spirals
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8323228B2 (en) 2007-04-12 2012-12-04 Rex Medical L.P. Dialysis catheter
US8328860B2 (en) 2007-03-13 2012-12-11 Covidien Lp Implant including a coil and a stretch-resistant member
US8439688B2 (en) 2005-04-07 2013-05-14 Jason D. Wilkins Orthopedic procedures training simulator
US8535294B2 (en) 2011-06-01 2013-09-17 Fischell Innovations Llc Carotid sheath with flexible distal section
US8591495B2 (en) 2011-02-23 2013-11-26 Fischell Innovations, Llc Introducer sheath with thin-walled shaft
US8591450B2 (en) 2010-06-07 2013-11-26 Rex Medical L.P. Dialysis catheter
US8747428B2 (en) * 2012-01-12 2014-06-10 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
US8777978B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
US9326774B2 (en) 2012-08-03 2016-05-03 Covidien Lp Device for implantation of medical devices
US9358014B2 (en) 1997-10-17 2016-06-07 Covidien Lp Device and method for controlling injection of liquid embolic composition
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9717503B2 (en) 2015-05-11 2017-08-01 Covidien Lp Electrolytic detachment for implant delivery systems
US9808256B2 (en) 2014-08-08 2017-11-07 Covidien Lp Electrolytic detachment elements for implant delivery systems
US9814466B2 (en) 2014-08-08 2017-11-14 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US9877729B2 (en) 2013-12-20 2018-01-30 Microvention, Inc. Catheter system
WO2017079325A3 (en) * 2015-11-03 2018-03-01 Clph, Llc Injection devices and systems and methods for using them

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827710B1 (en) 1996-11-26 2004-12-07 Edwards Lifesciences Corporation Multiple lumen access device
CN100341592C (en) * 1999-06-08 2007-10-10 爱德华兹生命科学公司 Multiple lumen access device
DK173411B2 (en) * 1998-06-19 2007-04-16 Coloplast As Collecting bag for human body wastes
US7044937B1 (en) * 1998-07-27 2006-05-16 Genzyme Corporation Universal modular surgical applicator systems
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
EP1185223A1 (en) * 1999-05-21 2002-03-13 Micro Therapeutics, Inc. Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity
US6645167B1 (en) 1999-05-21 2003-11-11 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an embolizing composition
US7018365B2 (en) 1999-05-21 2006-03-28 Micro Therapeutics, Inc. Threaded syringe with quick stop
WO2001003666A2 (en) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Liquid based vaso-occlusive compositions
US6679870B1 (en) * 1999-07-23 2004-01-20 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6685694B2 (en) * 1999-07-23 2004-02-03 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
AUPQ219799A0 (en) * 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6290689B1 (en) * 1999-10-22 2001-09-18 Corazón Technologies, Inc. Catheter devices and methods for their use in the treatment of calcified vascular occlusions
US6592544B1 (en) 1999-11-24 2003-07-15 Edwards Lifesciences Corporation Vascular access devices having hemostatic safety valve
US6652883B2 (en) * 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
US20050113798A1 (en) * 2000-07-21 2005-05-26 Slater Charles R. Methods and apparatus for treating the interior of a blood vessel
US20050107738A1 (en) * 2000-07-21 2005-05-19 Slater Charles R. Occludable intravascular catheter for drug delivery and method of using the same
US20030120256A1 (en) * 2001-07-03 2003-06-26 Syntheon, Llc Methods and apparatus for sclerosing the wall of a varicose vein
CA2574429A1 (en) * 2004-08-19 2006-03-02 Veinrx, Inc. An occludable intravascular catheter for drug delivery and method of using the same
US6890342B2 (en) 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
US6478775B1 (en) 2000-10-02 2002-11-12 Genyx Medical Inc. Device for delivering non-biodegradable bulking composition to a urological site
CA2432797C (en) 2000-12-18 2014-02-04 David J. Yang Local regional chemotherapy and radiotherapy using in situ hydrogel
AU2007201748B2 (en) * 2000-12-18 2009-11-19 Board Of Regents, The University Of Texas System Local regional chemotherapy and radiotherapy using in situ hydrogel
US7294137B2 (en) * 2001-03-27 2007-11-13 Boston Scientific Scimed Device for multi-modal treatment of vascular lesions
US6602269B2 (en) 2001-03-30 2003-08-05 Scimed Life Systems Embolic devices capable of in-situ reinforcement
US6905489B2 (en) * 2001-04-24 2005-06-14 Northgate Technologies, Inc. Laparoscopic insertion device
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US20030045859A1 (en) * 2001-06-11 2003-03-06 Larry Dominguez Delivery system using balloon catheter
JP2003050745A (en) * 2001-08-07 2003-02-21 Sony Corp Information processor, information processing method and computer program
US6663596B2 (en) 2001-08-13 2003-12-16 Scimed Life Systems, Inc. Delivering material to a patient
EP1460982A4 (en) * 2001-11-16 2010-04-14 Biocure Inc Methods for initiating in situ formation of hydrogels
US20060292206A1 (en) * 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
AU2003216141A1 (en) * 2002-01-25 2003-09-02 Biocure, Inc. Coaxial delivery device
US6758836B2 (en) 2002-02-07 2004-07-06 C. R. Bard, Inc. Split tip dialysis catheter
US20030171773A1 (en) * 2002-03-06 2003-09-11 Carrison Harold F. Methods for aneurysm repair
US20040147903A1 (en) * 2002-04-05 2004-07-29 Lucas Latini Microcatheter having tip relief region
US7771387B2 (en) * 2002-05-17 2010-08-10 Boston Scientific Scimed, Inc. Liquid embolic composition delivery devices and methods
US7338511B2 (en) * 2002-05-24 2008-03-04 Boston Scientific-Scimed, Inc. Solid embolic material with variable expansion
WO2003105697A1 (en) 2002-06-14 2003-12-24 Loma Linda University Medical Center Vascular wound closure device and method
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US7481821B2 (en) * 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
AU2003295963B2 (en) * 2002-11-25 2009-09-03 Boston Scientific Limited Injection device for treating mammalian body
US20040153025A1 (en) * 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US7744583B2 (en) * 2003-02-03 2010-06-29 Boston Scientific Scimed Systems and methods of de-endothelialization
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7393339B2 (en) 2003-02-21 2008-07-01 C. R. Bard, Inc. Multi-lumen catheter with separate distal tips
JP2006521180A (en) * 2003-03-25 2006-09-21 バイオキュア・インコーポレーテッドBiocure,Inc. Medical device according to the hydrogel yarn
US7651513B2 (en) * 2003-04-03 2010-01-26 Boston Scientific Scimed, Inc. Flexible embolic device delivery system
US8821473B2 (en) 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US20040243095A1 (en) 2003-05-27 2004-12-02 Shekhar Nimkar Methods and apparatus for inserting multi-lumen spit-tip catheters into a blood vessel
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
DE602004031953D1 (en) 2003-08-14 2011-05-05 Univ Loma Linda Med
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
EP1696806B1 (en) 2003-11-21 2012-08-29 Silk Road Medical, Inc. Apparatus for treating a carotid artery
US7294123B2 (en) * 2003-12-17 2007-11-13 Corris Neurovascular, Inc. Activatable bioactive vascular occlusive device and method of use
SE0303387L (en) * 2003-12-17 2005-01-25 Jan Skansen Catheter assembly and infusion system with inner and outer catheter
US20070167747A1 (en) * 2004-03-10 2007-07-19 Koninklijke Philips Electronics, N.V. Catheter, apparatus and method for therapeutic embolization
US7959634B2 (en) 2004-03-29 2011-06-14 Soteira Inc. Orthopedic surgery access devices
US7887529B2 (en) * 2004-04-19 2011-02-15 Boston Scientific Scimed, Inc. Hybrid micro guide catheter
US8992454B2 (en) 2004-06-09 2015-03-31 Bard Access Systems, Inc. Splitable tip catheter with bioresorbable adhesive
US7201918B2 (en) * 2004-11-16 2007-04-10 Microvention, Inc. Compositions, systems and methods for treatment of defects in blood vessels
US20080009784A1 (en) * 2004-11-22 2008-01-10 Leedle John D Dialysis catheter
US20060129091A1 (en) 2004-12-10 2006-06-15 Possis Medical, Inc. Enhanced cross stream mechanical thrombectomy catheter with backloading manifold
US8348908B2 (en) * 2004-12-16 2013-01-08 Smiths Medical Asd, Inc. Catheter with direction orientation
US7402151B2 (en) * 2004-12-17 2008-07-22 Biocardia, Inc. Steerable guide catheters and methods for their use
KR20060072734A (en) * 2004-12-23 2006-06-28 두산인프라코어 주식회사 Appareatus for supplying compressed air of construction heavy equipments
EP1880742B1 (en) * 2005-04-06 2017-05-31 Kaneka Corporation Catheter
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
DE102005019782A1 (en) * 2005-04-28 2006-11-09 Dendron Gmbh A device for implantation of occlusion helixes with internal securing means
US7780695B2 (en) * 2005-06-30 2010-08-24 Codman & Shurtleff, Inc. Chemically based vascular occlusion device deployment
CN101495047B (en) 2005-10-05 2011-12-28 洛马林达大学医学中心 The vessel wound closure apparatus and method
US20070265564A1 (en) * 2006-05-15 2007-11-15 Medtronic Vascular, Inc. Catheter Having Non-Blood-Contacting Exit Markers
US8377091B2 (en) 2006-06-15 2013-02-19 Microvention, Inc. Embolization device constructed from expansile polymer
US8167847B2 (en) 2006-06-22 2012-05-01 Excelsior Medical Corporation Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
US7732190B2 (en) 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US7922757B2 (en) * 2006-10-23 2011-04-12 Rex Medical, L.P. Vascular conduit
US8741326B2 (en) 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
US7909873B2 (en) 2006-12-15 2011-03-22 Soteira, Inc. Delivery apparatus and methods for vertebrostenting
US9480485B2 (en) 2006-12-15 2016-11-01 Globus Medical, Inc. Devices and methods for vertebrostenting
DE102006062187A1 (en) * 2006-12-22 2008-06-26 Biotronik Vi Patent Ag Catheter tube member
US8012117B2 (en) * 2007-02-06 2011-09-06 Medrad, Inc. Miniature flexible thrombectomy catheter
US20080188793A1 (en) * 2007-02-06 2008-08-07 Possis Medical, Inc. Miniature flexible thrombectomy catheter
US20080200873A1 (en) * 2007-02-16 2008-08-21 Alejandro Espinosa Methods and Apparatus for Infusing the Interior of a Blood Vessel
DE202007003734U1 (en) * 2007-03-14 2008-07-17 Markus, Kai Ulf, Dr. A multiple lumen microcatheter
WO2009017855A2 (en) * 2007-04-27 2009-02-05 Wisconsin Alumni Research Foundation Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent and a biocompatible metallic frame member
US8858490B2 (en) 2007-07-18 2014-10-14 Silk Road Medical, Inc. Systems and methods for treating a carotid artery
EP2173425B1 (en) 2007-07-18 2012-11-21 Silk Road Medical, Inc. Systems for establishing retrograde carotid arterial blood flow
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
US8500939B2 (en) 2007-10-17 2013-08-06 Bard Access Systems, Inc. Manufacture of split tip catheters
US8292841B2 (en) 2007-10-26 2012-10-23 C. R. Bard, Inc. Solid-body catheter including lateral distal openings
US8066660B2 (en) 2007-10-26 2011-11-29 C. R. Bard, Inc. Split-tip catheter including lateral distal openings
US9579485B2 (en) 2007-11-01 2017-02-28 C. R. Bard, Inc. Catheter assembly including a multi-lumen configuration
CN101918067B (en) 2007-11-01 2013-04-10 C·R·巴德股份有限公司 Catheter assembly including triple lumen tips
JP5698537B2 (en) 2007-12-21 2015-04-08 マイクロベンション インコーポレイテッド Hydrogel filament for biomedical use
US8684999B2 (en) * 2007-12-31 2014-04-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter shaft and method of manufacture
JP2011510796A (en) 2008-02-05 2011-04-07 シルク・ロード・メディカル・インコーポレイテッドSilk Road Medical, Inc. Interventional catheter system and method
US8157747B2 (en) * 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
WO2009155319A1 (en) 2008-06-17 2009-12-23 Soteira, Inc. Devices and methods for fracture reduction
US8109985B2 (en) * 2008-07-23 2012-02-07 Boston Scientific Scimed, Inc. Occlusion crossing device and method
US9011467B2 (en) 2008-08-13 2015-04-21 Silk Road Medical, Inc. Suture delivery device
US8574245B2 (en) 2008-08-13 2013-11-05 Silk Road Medical, Inc. Suture delivery device
AU2009282868B2 (en) * 2008-08-19 2013-09-05 Covidien Lp Detachable tip microcatheter
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
EP2379129B1 (en) 2008-12-23 2017-09-13 Silk Road Medical, Inc. Methods and systems for treatment of acute ischemic stroke
WO2010083167A2 (en) 2009-01-13 2010-07-22 Silk Road Medical, Inc. Methods and systems for performing neurointerventional procedures
US20100228269A1 (en) * 2009-02-27 2010-09-09 Garrison Michi E Vessel closure clip device
CA2785621C (en) 2009-04-02 2015-12-22 The Regents Of The University Of Colorado, A Body Corporate Vascular occlusion devices
AU2010313530B2 (en) 2009-10-26 2015-12-17 Microvention, Inc. Embolization device constructed from expansile polymer
AU2010339980C1 (en) * 2009-12-16 2014-07-10 Endoshape, Inc. Multi-fiber shape memory device
US9232805B2 (en) 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
EP2598195B1 (en) * 2010-07-26 2015-12-30 Steerable Instruments B.V.B.A. Capillary tube assembly
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
KR20150027764A (en) 2012-06-14 2015-03-12 마이크로벤션, 인코포레이티드 Polymeric treatment compositions
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
US10159479B2 (en) 2012-08-09 2018-12-25 Silk Road Medical, Inc. Suture delivery device
KR20150071025A (en) 2012-10-15 2015-06-25 마이크로벤션, 인코포레이티드 Polymeric treatment compositions
JP2015534855A (en) * 2012-11-07 2015-12-07 スリーエヌティー・メディカル・リミテッド Sinus Access System
US9833272B2 (en) 2012-11-16 2017-12-05 Spinal Generations, Llc Multichannel cannula and methods for using same
US20140154796A1 (en) * 2012-12-03 2014-06-05 Stanislav L. Karsten Sampling Device and Method for Collection and Preservation of Live Cells from Tissues and Cell Cultures
US20140163367A1 (en) * 2012-12-07 2014-06-12 Covidien Lp Microcatheter
USD748252S1 (en) 2013-02-08 2016-01-26 C. R. Bard, Inc. Multi-lumen catheter tip
AU2014243881B2 (en) 2013-03-13 2017-04-13 Endoshape Inc. Continuous embolic coil and methods and devices for delivery of the same
WO2015006444A1 (en) * 2013-07-10 2015-01-15 Merit Medical Systems, Inc. Pre-loaded syringes and methods related thereto
US10226333B2 (en) 2013-10-15 2019-03-12 Cedars-Sinai Medical Center Anatomically-orientated and self-positioning transcatheter mitral valve
GB2520562B (en) * 2013-11-26 2017-07-26 Cook Medical Technologies Llc System and method for delivering material into a patient
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US9987014B2 (en) * 2014-02-06 2018-06-05 Boston Scientific Scimed, Inc. Occlusion device
US10124090B2 (en) 2014-04-03 2018-11-13 Terumo Corporation Embolic devices
US20150305892A1 (en) * 2014-04-25 2015-10-29 Abbott Cardiovascular Systems Inc. Methods and Devices for Treating a Bodily Lumen with In Situ Generated Structural Support
WO2015167752A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US10182801B2 (en) 2014-05-16 2019-01-22 Silk Road Medical, Inc. Vessel access and closure assist system and method
US9241699B1 (en) 2014-09-04 2016-01-26 Silk Road Medical, Inc. Methods and devices for transcarotid access
JPWO2016063824A1 (en) * 2014-10-20 2017-08-31 国立大学法人 鹿児島大学 Embolizing formulations and microcatheter
US9615863B2 (en) 2014-10-22 2017-04-11 Spinal Generations, Llc Multichannel cannula for kyphoplasty and method of use
US20160129220A1 (en) * 2014-11-10 2016-05-12 Regents Of The University Of Minnesota Catheter devices, systems and methods for injection of adhesive materials
CN108697879A (en) * 2016-03-22 2018-10-23 泰尔茂株式会社 Long body for medical use

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364392A (en) * 1980-12-04 1982-12-21 Wisconsin Alumni Research Foundation Detachable balloon catheter
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4819637A (en) * 1987-09-01 1989-04-11 Interventional Therapeutics Corporation System for artificial vessel embolization and devices for use therewith
US5041090A (en) * 1988-01-12 1991-08-20 Scheglov Viktor I Occluding device
US5156596A (en) * 1991-02-04 1992-10-20 Menlo Care, Inc. Catheter with changeable number of lumens
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5207648A (en) * 1990-12-14 1993-05-04 The Kendall Company Multilumen catheter
US5395353A (en) * 1993-11-02 1995-03-07 Vascular Technologies, Inc. Guiding catheter with controllable perfusion ports
US5443454A (en) * 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5695480A (en) * 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5733267A (en) * 1995-04-05 1998-03-31 Scimed Life Systems, Inc. Pull back stent delivery system
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5776097A (en) * 1996-12-19 1998-07-07 University Of California At Los Angeles Method and device for treating intracranial vascular aneurysms
US5795331A (en) * 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
US5830178A (en) * 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US5895385A (en) * 1990-03-13 1999-04-20 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5921954A (en) * 1996-07-10 1999-07-13 Mohr, Jr.; Lawrence G. Treating aneurysms by applying hardening/softening agents to hardenable/softenable substances
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468216A (en) * 1982-05-20 1984-08-28 Rudolph Muto Irrigation suction catheter
AU613886B2 (en) 1986-11-29 1991-08-15 Terumo Kabushiki Kaisha Catheter equipped with balloon
US5167622A (en) * 1990-12-07 1992-12-01 Smiths Industries Medical Systems, Inc. Triple conduit suction catheter
US5382260A (en) * 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
ES2227547T3 (en) * 1994-03-18 2005-04-01 Cook Incorporated Helical embolization coil.
WO1996004954A1 (en) * 1994-08-17 1996-02-22 Boston Scientific Corporation Implant, and method and device for inserting the implant
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
NO962336A (en) * 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-occlusive coil
US5888546A (en) * 1995-08-28 1999-03-30 The Regents Of The University Of California Embolic material for endovascular occlusion of abnormal vasculature and method for using the same
US6638293B1 (en) 1996-02-02 2003-10-28 Transvascular, Inc. Methods and apparatus for blocking flow through blood vessels
DE19610333A1 (en) 1996-03-17 1997-09-18 M Dr Mausbach Apparatus and process for introduction and release of implant in vivo
EP0928195B1 (en) * 1996-05-31 2003-01-02 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5925683A (en) * 1996-10-17 1999-07-20 Target Therapeutics, Inc. Liquid embolic agents
US5958444A (en) * 1997-06-13 1999-09-28 Micro Therapeutics, Inc. Method for treating urinary reflux
DE69941894D1 (en) 1998-02-10 2010-02-25 Artemis Medical Inc Occlusion, mooring, voltage or current control device
US6165193A (en) 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364392A (en) * 1980-12-04 1982-12-21 Wisconsin Alumni Research Foundation Detachable balloon catheter
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4819637A (en) * 1987-09-01 1989-04-11 Interventional Therapeutics Corporation System for artificial vessel embolization and devices for use therewith
US5041090A (en) * 1988-01-12 1991-08-20 Scheglov Viktor I Occluding device
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5895385A (en) * 1990-03-13 1999-04-20 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5207648A (en) * 1990-12-14 1993-05-04 The Kendall Company Multilumen catheter
US5156596A (en) * 1991-02-04 1992-10-20 Menlo Care, Inc. Catheter with changeable number of lumens
US5443454A (en) * 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
US5395353A (en) * 1993-11-02 1995-03-07 Vascular Technologies, Inc. Guiding catheter with controllable perfusion ports
US5795331A (en) * 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
US5733267A (en) * 1995-04-05 1998-03-31 Scimed Life Systems, Inc. Pull back stent delivery system
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5921954A (en) * 1996-07-10 1999-07-13 Mohr, Jr.; Lawrence G. Treating aneurysms by applying hardening/softening agents to hardenable/softenable substances
US5695480A (en) * 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5830178A (en) * 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US5776097A (en) * 1996-12-19 1998-07-07 University Of California At Los Angeles Method and device for treating intracranial vascular aneurysms
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358014B2 (en) 1997-10-17 2016-06-07 Covidien Lp Device and method for controlling injection of liquid embolic composition
US8597321B2 (en) 1999-10-30 2013-12-03 Covidien Lp Device for the implantation of occlusion spirals
US8048104B2 (en) 2000-10-30 2011-11-01 Dendron Gmbh Device for the implantation of occlusion spirals
US7799014B2 (en) 2001-01-09 2010-09-21 Rex Medical, L.P. Dialysis catheter
US8500674B2 (en) 2001-01-09 2013-08-06 Rex Medical, L.P. Dialysis catheter
US9084850B2 (en) 2001-01-09 2015-07-21 Rex Medical L.P. Dialysis catheter
US8282024B2 (en) * 2003-06-26 2012-10-09 Advanced Cardiovascular Systems, Inc. Stent coating nozzle assembly
US20080121175A1 (en) * 2003-06-26 2008-05-29 Stephen Dirk Pacetti Stent Coating Nozzle Assembly
US20100076479A1 (en) * 2004-01-21 2010-03-25 Hermann Monstadt Device for implanting electrically isolated occlusion helixes
US9254134B2 (en) 2004-01-21 2016-02-09 Dendron Gmbh Device for implanting electrically isolated occlusion helixes
US8480701B2 (en) 2004-01-21 2013-07-09 Dendron Gmbh Device for implanting electrically isolated occlusion helixes
US20110118777A1 (en) * 2004-05-21 2011-05-19 Micro Therapeutics, Inc. Metallic coils enlaced with fibers for embolization of a body cavity
US7896899B2 (en) 2004-05-21 2011-03-01 Micro Therapeutics, Inc. Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
US8267955B2 (en) 2004-05-21 2012-09-18 Tyco Healthcare Group Lp Metallic coils enlaced with fibers for embolization of a body cavity
US20060036281A1 (en) * 2004-05-21 2006-02-16 Micro Therapeutics, Inc. Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US7879064B2 (en) 2004-09-22 2011-02-01 Micro Therapeutics, Inc. Medical implant
US20110098814A1 (en) * 2004-09-22 2011-04-28 Micro Therapeutics, Inc. Medical implant
US9198665B2 (en) 2004-09-22 2015-12-01 Covidien Lp Micro-spiral implantation device
US8372110B2 (en) 2004-09-22 2013-02-12 Covidien Lp Medical implant
US8845676B2 (en) 2004-09-22 2014-09-30 Micro Therapeutics Micro-spiral implantation device
US8439688B2 (en) 2005-04-07 2013-05-14 Jason D. Wilkins Orthopedic procedures training simulator
WO2007047109A3 (en) * 2005-10-12 2007-12-21 Boston Scient Scimed Inc Embolic coil introducer sheath locking mechanisms
WO2007047109A2 (en) * 2005-10-12 2007-04-26 Boston Scientific Scimed, Inc. Embolic coil introducer sheath locking mechanisms
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8795320B2 (en) 2006-04-17 2014-08-05 Covidien Lp System and method for mechanically positioning intravascular implants
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
US8777978B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
US8795321B2 (en) 2006-04-17 2014-08-05 Covidien Lp System and method for mechanically positioning intravascular implants
EP2036485A3 (en) * 2006-08-28 2010-04-14 Olympus Medical Systems Corporation Ultrasonic endoscope, therapeutic system, endoscopic system, T-bar, und T-bar suturing device
US8328860B2 (en) 2007-03-13 2012-12-11 Covidien Lp Implant including a coil and a stretch-resistant member
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US9289215B2 (en) 2007-03-13 2016-03-22 Covidien Lp Implant including a coil and a stretch-resistant member
US8323228B2 (en) 2007-04-12 2012-12-04 Rex Medical L.P. Dialysis catheter
US20100125324A1 (en) * 2008-11-14 2010-05-20 Medtronic Vascular, Inc. Catheter Inner Member
WO2010056518A3 (en) * 2008-11-14 2010-12-09 Medtronic Vascular, Inc. Catheter inner member
US9149601B2 (en) 2010-06-07 2015-10-06 Rex Medical, L.P. Dialysis catheter
US8591450B2 (en) 2010-06-07 2013-11-26 Rex Medical L.P. Dialysis catheter
US8591495B2 (en) 2011-02-23 2013-11-26 Fischell Innovations, Llc Introducer sheath with thin-walled shaft
US8535294B2 (en) 2011-06-01 2013-09-17 Fischell Innovations Llc Carotid sheath with flexible distal section
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US8747428B2 (en) * 2012-01-12 2014-06-10 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US9302083B2 (en) 2012-01-12 2016-04-05 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US9119935B2 (en) 2012-01-12 2015-09-01 Fischell Innovations, Llc Carotid sheath with entry and tracking rapid exchange dilators and method of use
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9326774B2 (en) 2012-08-03 2016-05-03 Covidien Lp Device for implantation of medical devices
US9877729B2 (en) 2013-12-20 2018-01-30 Microvention, Inc. Catheter system
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9808256B2 (en) 2014-08-08 2017-11-07 Covidien Lp Electrolytic detachment elements for implant delivery systems
US9814466B2 (en) 2014-08-08 2017-11-14 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US9717503B2 (en) 2015-05-11 2017-08-01 Covidien Lp Electrolytic detachment for implant delivery systems
WO2017079325A3 (en) * 2015-11-03 2018-03-01 Clph, Llc Injection devices and systems and methods for using them

Also Published As

Publication number Publication date
DE69820105D1 (en) 2004-01-08
DE69820105T2 (en) 2004-09-16
EP1030703A1 (en) 2000-08-30
EP1030703B1 (en) 2003-11-26
EP1030703A4 (en) 2000-11-22
US6558367B1 (en) 2003-05-06
JP2001520085A (en) 2001-10-30
US6964657B2 (en) 2005-11-15
US20030225391A1 (en) 2003-12-04
AU1697799A (en) 1999-05-10
ES2210851T3 (en) 2004-07-01
AT254937T (en) 2003-12-15
CA2306992A1 (en) 1999-04-29
WO1999020326A1 (en) 1999-04-29
US6146373A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
Klein et al. Endovascular treatment of renal artery aneurysms with conventional non‐detachable microcoils and Guglielmi detachable coils
AU762604B2 (en) Catheters, systems and methods for percutaneous in situ arterio-venous bypass
US6790204B2 (en) Method for containing and removing occlusions in the carotid arteries
US8075586B2 (en) Embolic protection device having expandable trap
US6905503B2 (en) Methods and devices for delivering occlusion elements
US6493589B1 (en) Methods and apparatus for treatment of pulmonary conditions
JP4762228B2 (en) Rapid exchange interventional device and method
US7468027B2 (en) Partial aortic occlusion devices and methods for cerebral perfusion augmentation
White Jr et al. Embolotherapy with detachable silicone balloons: technique and clinical results
US5527338A (en) Intravascular device
JP4480901B2 (en) Method of treating endoleaks during endovascular repair of abdominal aortic aneurysms
JP4267927B2 (en) Embolic introduction prevention device
US6398773B1 (en) Aspiration system and method
US8979793B2 (en) Methods and devices for percutaneous and surgical interventions
JP4898993B2 (en) Intravascular medical device comprising a plurality of wires
US8388650B2 (en) Systems and methods for supporting or occluding a physiological opening or cavity
US7744583B2 (en) Systems and methods of de-endothelialization
ES2360214T3 (en) Threaded syringe with a quick stop.
US8292850B2 (en) Coaxial guide catheter for interventional cardiology procedures
EP2617366B1 (en) Asymmetrical medical devices for treating a target site and associated method
US7914503B2 (en) Method and apparatus for selective material delivery via an intra-renal catheter
CA2714107C (en) Medical devices for treating a target site and associated method
US5443478A (en) Multi-element intravascular occlusion device
CA2399386C (en) Angioplasty device and method of making same
US5554114A (en) Infusion device with preformed shape